NIM
RCUS icon

NEOS Investment Management’s Arcus Biosciences RCUS Stock Holding History

NEOS Investment Management’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-36,665
Closed -$874K – 639
2025
Q4 		$874K Buy
36,665
+6,372
+21% +$130K 0.01% 564
2025
Q3 		$412K Sell
30,293
-29,369
-49% -$305K ﹤0.01% 593
2025
Q2 		$486K Buy
59,662
+44,411
+291% +$379K 0.01% 549
2025
Q1 		$120K Sell
15,251
-6,982
-31% -$80.9K ﹤0.01% 595
2024
Q4 		$331K Sell
22,233
-14,705
-40% -$240K 0.01% 548
2024
Q3 		$565K Buy
36,938
+2,332
+7% +$36.8K 0.02% 474
2024
Q2 		$527K Buy
34,606
+23,129
+202% +$373K 0.02% 441
2024
Q1 		$217K Buy
11,477
+336
+3% +$5.81K 0.01% 540
2023
Q4 		$213K Buy
+11,141
New +$178K 0.02% 487

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

NEOS Investment Management's RCUS Position: Q1 2026 in Review

NEOS Investment Management sold out of Arcus Biosciences (RCUS) in Q1 2026, closing a stake of 36,665 shares — an estimated $874K sold.

NEOS Investment Management first reported a position in RCUS in Q4 2023 and held it in 9 quarters. The position peaked at $874K in Q4 2025. 211 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

  • NEOS Investment Management reported no remaining Arcus Biosciences position as of Q1 2026 after selling out during the quarter.
  • NEOS Investment Management sold 36,665 Arcus Biosciences shares in Q1 2026, an estimated $874K.
  • NEOS Investment Management first reported a position in Arcus Biosciences in Q4 2023 and held it in 9 quarters.
  • NEOS Investment Management's Arcus Biosciences position peaked at $874K in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on NEOS Investment Management's 13F filing for Q1 2026, filed 15 May 2026.